A Study to Evaluate ITCA 650 for the Treatment of Type 2 Diabetes

NCT01455857 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

460

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: ITCA 650
OTHER: ITCA placebo

Sponsor

Intarcia Therapeutics